NitroMed Home
NitroMed Pipeline Technology News: Press Releases Investors Careers
About NitroMed

Board of Directors and Leadership

Community Support

Supplier Diversity

BOARD OF DIRECTORS

Mark Leschly has served as a member of our board of directors since September 1996. Since July 1999, Mr. Leschly has been a Managing Partner with Rho Capital Partners, an investment and venture capital management company. Starting in July 1994 to July 1999, Mr. Leschly was a principal and then a General Partner of HealthCare Ventures, L.L.C., a venture capital management company. From September 1991 to June 1993, Mr. Leschly served as a consultant for McKinsey & Co., a management consulting company. He also serves as a director of Diversa Corporation, Tercica, Inc. and Senomyx, Inc., each biotechnology companies. Mr. Leschly holds a B.A. degree from Harvard University and an M.B.A. from the Stanford Graduate School of Business.


  BOARD OF DIRECTORS

  Argeris Karabelas, Ph.D.

  Kenneth M. Bate

  Joseph Loscalzo, M.D., Ph.D.

  Robert S. Cohen

  Frank L. Douglas, M.D., Ph.D.

  Zola Horovitz, Ph.D.

  Mark Leschly

  John W. Littlechild

  Davey S. Scoon, C.P.A.

  Christopher J. Sobecki

 

 
NitroMed | BiDil | Technology | News | Investors | Careers
Privacy Policy | Legal Notice | MSDS
Copyright © 2007 NitroMed, Inc. All Rights Reserved.
Contact Site Map Media Center Home